Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome.

Maria Piccione, Mottadelli, Lopez-Atalaya, Silvia Spena, Cristina Gervasini, Angelo Selicorni, Scarano, Lidia Larizza, Barco

Risultato della ricerca: Article

43 Citazioni (Scopus)

Abstract

ABSTRACTBackground RubinsteineTaybi syndrome (RSTS) isa congenital neurodevelopmental disorder defined bypostnatal growth deficiency, characteristic skeletalabnormalities and mental retardation and caused bymutations in the genes encoding for the transcriptionalco-activators with intrinsic lysine acetyltransferase (KAT)activity CBP and p300. Previous studies have shown thatneuronal histone acetylation is reduced in mouse modelsof RSTS.Methods The authors identified different mutations atthe CREBBP locus and generated lymphoblastoid celllines derived from nine patients with RSTS carryingdistinct CREBBP mutations that illustrate different gradesof the clinical severity in the spectrum of the syndrome.They next assessed whether histone acetylation levelswere altered in these cell lines.Results The comparison of CREBBP-mutated RSTS celllines with cell lines derived from patients with anunrelated mental retardation syndrome or healthycontrols revealed significant deficits in histoneacetylation, affecting primarily histone H2B and histoneH2A. The most severe defects were observed in the linescarrying the whole deletion of the CREBBP gene and thetruncating mutation, both leading to a haploinsufficiencystate. Interestingly, this deficit was rescued by treatmentwith an inhibitor of histone deacetylases (HDACi).Conclusions The authors’ results extend to humans theseminal observations in RSTS mouse models and point tohistone acetylation defects, mainly involving H2B andH2A, as relevant molecular markers of the disease.
Lingua originaleEnglish
pagine (da-a)66-74
Numero di pagine9
RivistaJournal of Medical Genetics
Volume1
Stato di pubblicazionePublished - 2012

Fingerprint

Rubinstein-Taybi Syndrome
Acetylation
Histones
Cell Line
Intellectual Disability
Mutation
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Histone Deacetylases
Gene Deletion

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cita questo

Piccione, M., Mottadelli, Lopez-Atalaya, Spena, S., Gervasini, C., Selicorni, A., ... Barco (2012). Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome. Journal of Medical Genetics, 1, 66-74.

Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome. / Piccione, Maria; Mottadelli; Lopez-Atalaya; Spena, Silvia; Gervasini, Cristina; Selicorni, Angelo; Scarano; Larizza, Lidia; Barco.

In: Journal of Medical Genetics, Vol. 1, 2012, pag. 66-74.

Risultato della ricerca: Article

Piccione, M, Mottadelli, Lopez-Atalaya, Spena, S, Gervasini, C, Selicorni, A, Scarano, Larizza, L & Barco 2012, 'Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome.', Journal of Medical Genetics, vol. 1, pagg. 66-74.
Piccione, Maria ; Mottadelli ; Lopez-Atalaya ; Spena, Silvia ; Gervasini, Cristina ; Selicorni, Angelo ; Scarano ; Larizza, Lidia ; Barco. / Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome. In: Journal of Medical Genetics. 2012 ; Vol. 1. pagg. 66-74.
@article{dcbb478318b449fcb34b72cc88b38b80,
title = "Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome.",
abstract = "ABSTRACTBackground RubinsteineTaybi syndrome (RSTS) isa congenital neurodevelopmental disorder defined bypostnatal growth deficiency, characteristic skeletalabnormalities and mental retardation and caused bymutations in the genes encoding for the transcriptionalco-activators with intrinsic lysine acetyltransferase (KAT)activity CBP and p300. Previous studies have shown thatneuronal histone acetylation is reduced in mouse modelsof RSTS.Methods The authors identified different mutations atthe CREBBP locus and generated lymphoblastoid celllines derived from nine patients with RSTS carryingdistinct CREBBP mutations that illustrate different gradesof the clinical severity in the spectrum of the syndrome.They next assessed whether histone acetylation levelswere altered in these cell lines.Results The comparison of CREBBP-mutated RSTS celllines with cell lines derived from patients with anunrelated mental retardation syndrome or healthycontrols revealed significant deficits in histoneacetylation, affecting primarily histone H2B and histoneH2A. The most severe defects were observed in the linescarrying the whole deletion of the CREBBP gene and thetruncating mutation, both leading to a haploinsufficiencystate. Interestingly, this deficit was rescued by treatmentwith an inhibitor of histone deacetylases (HDACi).Conclusions The authors’ results extend to humans theseminal observations in RSTS mouse models and point tohistone acetylation defects, mainly involving H2B andH2A, as relevant molecular markers of the disease.",
author = "Maria Piccione and Mottadelli and Lopez-Atalaya and Silvia Spena and Cristina Gervasini and Angelo Selicorni and Scarano and Lidia Larizza and Barco",
year = "2012",
language = "English",
volume = "1",
pages = "66--74",
journal = "Journal of Medical Genetics",
issn = "0022-2593",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome.

AU - Piccione, Maria

AU - Mottadelli, null

AU - Lopez-Atalaya, null

AU - Spena, Silvia

AU - Gervasini, Cristina

AU - Selicorni, Angelo

AU - Scarano, null

AU - Larizza, Lidia

AU - Barco, null

PY - 2012

Y1 - 2012

N2 - ABSTRACTBackground RubinsteineTaybi syndrome (RSTS) isa congenital neurodevelopmental disorder defined bypostnatal growth deficiency, characteristic skeletalabnormalities and mental retardation and caused bymutations in the genes encoding for the transcriptionalco-activators with intrinsic lysine acetyltransferase (KAT)activity CBP and p300. Previous studies have shown thatneuronal histone acetylation is reduced in mouse modelsof RSTS.Methods The authors identified different mutations atthe CREBBP locus and generated lymphoblastoid celllines derived from nine patients with RSTS carryingdistinct CREBBP mutations that illustrate different gradesof the clinical severity in the spectrum of the syndrome.They next assessed whether histone acetylation levelswere altered in these cell lines.Results The comparison of CREBBP-mutated RSTS celllines with cell lines derived from patients with anunrelated mental retardation syndrome or healthycontrols revealed significant deficits in histoneacetylation, affecting primarily histone H2B and histoneH2A. The most severe defects were observed in the linescarrying the whole deletion of the CREBBP gene and thetruncating mutation, both leading to a haploinsufficiencystate. Interestingly, this deficit was rescued by treatmentwith an inhibitor of histone deacetylases (HDACi).Conclusions The authors’ results extend to humans theseminal observations in RSTS mouse models and point tohistone acetylation defects, mainly involving H2B andH2A, as relevant molecular markers of the disease.

AB - ABSTRACTBackground RubinsteineTaybi syndrome (RSTS) isa congenital neurodevelopmental disorder defined bypostnatal growth deficiency, characteristic skeletalabnormalities and mental retardation and caused bymutations in the genes encoding for the transcriptionalco-activators with intrinsic lysine acetyltransferase (KAT)activity CBP and p300. Previous studies have shown thatneuronal histone acetylation is reduced in mouse modelsof RSTS.Methods The authors identified different mutations atthe CREBBP locus and generated lymphoblastoid celllines derived from nine patients with RSTS carryingdistinct CREBBP mutations that illustrate different gradesof the clinical severity in the spectrum of the syndrome.They next assessed whether histone acetylation levelswere altered in these cell lines.Results The comparison of CREBBP-mutated RSTS celllines with cell lines derived from patients with anunrelated mental retardation syndrome or healthycontrols revealed significant deficits in histoneacetylation, affecting primarily histone H2B and histoneH2A. The most severe defects were observed in the linescarrying the whole deletion of the CREBBP gene and thetruncating mutation, both leading to a haploinsufficiencystate. Interestingly, this deficit was rescued by treatmentwith an inhibitor of histone deacetylases (HDACi).Conclusions The authors’ results extend to humans theseminal observations in RSTS mouse models and point tohistone acetylation defects, mainly involving H2B andH2A, as relevant molecular markers of the disease.

UR - http://hdl.handle.net/10447/78672

M3 - Article

VL - 1

SP - 66

EP - 74

JO - Journal of Medical Genetics

JF - Journal of Medical Genetics

SN - 0022-2593

ER -